After dosing with Cognition’s CT1812, study reports declines of 95% and higher in subgroup with below-median p-tau217.

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

Tensions flared in Belagavi, Karnataka, after a poster depicting Mughal emperor Aurangzeb as the "real founder of Akhand Bharat" was removed by police. The poster, installed by unidentified youths ...

Dozens of candidates are running in the 2024 presidential election apart from Kamala Harris and Donald Trump, which may influence the final result in the tight race. None is on a realistic path to the ...

Sydney’s west has seen an explosion of development in the past 20 years. Its latest project is the one we can be most proud of.